Showing results (1-10 of 374) with videos related to

Sort By:
Pageof 38
The Lancet Regional Health. Europe|September 23, 2024
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisMark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, et al.
The Lancet. Oncology|March 29, 2023
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P Lythgoe, Jonathan Krell, Mark Bower, et al.
Trends in Pharmacological Sciences|April 16, 2020
Ongoing Clinical Trials for the Management of the COVID-19 PandemicMark P Lythgoe, Paul Middleton
British Journal of Cancer|June 23, 2022
Repositioning canakinumab for non-small cell lung cancer-important lessons for drug repurposing in oncologyMark P Lythgoe, Vinay Prasad
Journal of Immunology Research|September 18, 2015
Application of "Systems Vaccinology" to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative VaccinesDavid J M Lewis, Mark P Lythgoe
European Journal of Cancer (Oxford, England : 1990)|November 4, 2021
The iceberg plot, improving the visualisation of therapy response in oncology in the era of sequence-directed therapyMark P Lythgoe, Timothée Olivier, Vinay Prasad
BMJ Open Gastroenterology|October 22, 2021
Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studiesPaul Middleton, Catherine Hsu, Mark P Lythgoe
Expert Opinion on Pharmacotherapy|October 8, 2020
Advances in cyclin-dependent kinase inhibitors for the treatment of melanomaMaximilian Julve, James J Clark, Mark P Lythgoe
Cancers|August 27, 2021
Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine NeoplasiasRohini Sharma, Mark P Lythgoe, Bhavandeep Slaich, et al.
JAMA Network Open|November 18, 2021
Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020Alyson Haslam, Mark P Lythgoe, Emma Greenstreet Akman, et al.
Pageof 38